Blockbuster Keytruda makes up nearly half of Merck’s sales. That’s becoming an issue.

With the best photo storage and sharing sites, your treasured memories are securely backed up in case something happens to your phone or hard drive, and you can easily manage and access your ...

When it comes to the best photo printers, what I want to see are quick print speeds and high-resolution images that are vivid, color-accurate, and effortlessly printed on glossy photo paper.

The best laptop for photo editing will smoothly run any photo editing software and improve your design flow - and we've run the tests to prove it. My team and I have extensively benchmarked and ...

I’ve been reviewing software for PCMag since 2008, and I still get a kick out of seeing what's new in video and photo editing software, and how operating systems change over time. I was ...

Exclusive-Kennedy Played Key Role in Vaccine Case Against Merck By Dan Levine and Mike Spector (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against ...

Jan 18 (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los ...

What’s the best digital photo frame? We’ve tested dozens of models at all different prices, and our top pick is the Aura Mason. Its 9-inch display is beautiful and has a resolution of 1600 x ...

Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug, Januvia. Merck faces broader industry pressure as vaccine skeptic Robert F. Kennedy Jr. possibly next ...

Analyst Daina Graybosch of Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research Report), reducing the price target to $119.00. Discover outperforming stocks and invest ...

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year. After an explosive opening marked by a suite of ...

Merck (NYSE:MRK) is preparing to launch a subcutaneously delivered formulation of their blockbuster cancer medication Keytruda for patient convenience as the company approaches a steep patent ...